Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Berylliosis (Disease Or Phenotype)

Nci:C197848

Msh:D001607

Mondo:MONDO:15274

Medcin:MEDCIN:212154

Mdr:MDR:10004485

Id:2d5b916a-f125-5aff-a64c-b917854400b7

Icpc2icd10eng:MTHU045934

Icd10cm:J63.2

Efo:EFO:7168

Doid:DOID:10322

Chv:CHV:1815

Results found

Linked to

	Label	Description
	betamethasone indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone hemisuccinate indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone Acetonide indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Triamcinolone diacetate indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Betamethasone acetate indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dexamethasone indication Berylliosis Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone hemisuccinate indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone Acetonide indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Triamcinolone diacetate indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Betamethasone acetate indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dexamethasone indication Berylliosis

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.